Within one week after quality test, Sputnik V will be approve for the distribution to states & UTs

The Central Drugs Laboratory (CDL) is likely to clear a batch of the Russian Covid-19 vaccine, Sputnik V, within a week.

The CDL, which is responsible for testing the safety and quality of vaccines for humans in India, has started conducting tests on 100 ampoules (glass vials) of Sputnik V out of a batch of 1.5 lakh ampoules that were imported by Dr Reddy’s, a Hyderabad-based pharmaceutical company.

On 13 April, India’s drug regulator DCGI granted permission for the restricted emergency use of Sputnik V.

Once it passes all regulatory tests, Sputnik V will be the third vaccine to be available in the country.

Pharma company Dr Reddy’s had applied for emergency use of the Sputnik-V vaccine in India.

Testing process

The testing of the Sputnik V vials began recently, according to the CDL official quoted above, and the 100 samples were selected randomly by the assistant drug controllers who were on port duty when the shipment landed.

Once the samples are checked for safety and efficacy, we send the testing report to the authorities concerned including DCGI and the Ministry of Health. Next is their call on whether to approve it for further distribution or raise red flags.

Leave a Comments here

Message us
Need Help?
Have you any Inquiry? Please leave a message. Our team will reply ASA
%d bloggers like this: